Spots Global Cancer Trial Database for A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
Official Title: A Phase 1b, Open-label, Dose-Finding Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Subjects With Newly Diagnosed Glioblastoma
Study ID: NCT04324840
Conditions
Study Description
Brief Summary: The purpose of this study is to determine the safety and tolerability of CC-90010 when combined with standard of care treatment, temozolomide (TMZ) with or without radiotherapy (RT) in the newly diagnosed WHO Grade IV glioblastoma (ndGBM).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 800, New York, New York, United States
Local Institution - 503, Aalborg, , Denmark
Local Institution - 501, Copenhagen, , Denmark
Local Institution - 500, Odense, , Denmark
Local Institution - 201, Milano, , Italy
Local Institution - 202, Milan, , Italy
Local Institution - 204, Padova, , Italy
Local Institution - 200, Verona, , Italy
Local Institution - 408, Leiden, Zuid-Holland, Netherlands
Local Institution - 405, Amsterdam, , Netherlands
Local Institution - 400, Rotterdam, , Netherlands
Local Institution - 401, Utrecht, , Netherlands
Local Institution - 600, Oslo, , Norway
Local Institution - 311, A Coruna, , Spain
Local Institution - 306, Barcelona, , Spain
Local Institution - 302, Barcelona, , Spain
Local Institution - 303, Barcelona, , Spain
Local Institution - 307, Hospitalet de Llobregat, Barcelona, , Spain
Local Institution - 304, Madrid, , Spain
Local Institution - 301, Madrid, , Spain
Local Institution - 300, Madrid, , Spain
Local Institution - 310, Pamplona, , Spain
Local Institution - 309, Sevilla, , Spain
Local Institution - 305, Valencia, , Spain
Local Institution - 312, Vigo, , Spain
Local Institution - 702, Goteborg, , Sweden
Local Institution - 701, Lund, , Sweden
Local Institution - 700, Solna, , Sweden
Local Institution - 703, Uppsala, , Sweden
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
